miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines

Author： Gu Jingyi  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.28, Iss.1, 2011-03, pp. : 211-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Artesunate possesses anti-leukemia properties that can be enhanced by arsenic trioxide

By Li Ying   Feng Lili   Li Ying   Jiang Wen   Shan Ningning   Wang Xin  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1366-1372

Informa Healthcare

Access to resources Recommend Favorite

Proteasome Inhibition in Myelodysplastic Syndromes and Acute Myelogenous Leukemia Cell Lines

By Liesveld Jane L.   Rosell Karen E.   Bechelli Jeremy   Lu Chaohui   Messina Patti   Mulford Deborah   Ifthikharuddin J. J.   Jordan Craig T.   Phillips II Gordon L.  

Cancer Investigation, Vol. 29, Iss. 7, 2011-07 ,pp. : 439-450

Informa Healthcare

Access to resources Recommend Favorite

Identification of miRNA-21 and miRNA-24 in plasma as potential early stage markers of acute cerebral infarction

By    

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-01 ,pp. : 971-976

Spandidos Publications

Access to resources Recommend Favorite

A correlation analysis of miRNA34a and its predicted target genes in leukemia

By              

Molecular Medicine Reports, Vol. 9, Iss. 4, 2014-01 ,pp. : 1283-1288

Spandidos Publications

Access to resources Recommend Favorite

Expression and significance of miRNA-21 and BTG2 in lung cancer

By Sun Qing   Hang Meng   Guo Xuedan   Shao Wenlong   Zeng Guangqiao  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 4017-4026

Springer Publishing Company

Access to resources Recommend Favorite